
DCP · Dis-Chem Pharmacies Limited
27.21
ZARUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
R23.94B
PE
0.00
EV/EBITDA
N/A
DIV Yield
0%
Payout Ratio
40%
MQV Rating
5Very Weak
As at 16/10/2026 12:00:00 AM
Price Chart
Description
- All-Companies
- All-Consensus
- HALO 100
- HALO 200
- HALO All
Key Fundamentals
EPS 3 yr Growth
1.70%
EBITDA Margin
7.30%
Operating Cashflow
R2,317m
Free Cash Flow Return
N/A
ROIC
N/A
Interest Coverage
5.60
Quick Ratio
N/A
Performance
52 weeks range
Low 25.35 - 39
Trade Value (12mth)
US$579,249.00
1 week
3.96%
1 month
6.1%
YTD
-21.32%
1 year
-15.67%
All time high
40.00
Additional Data
Shares Outstanding (Fully Diluted)
857m
HALO Sector
Healthcare
Next Company Report Date
28-May-27
Next Ex Dividend Date
17-Jun-26
Next Dividend Pay Date
22-Jun-26
Reporting Currency
ZAR
Short Sell (% of issue)
0.00
Health Scores
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Very Strong
Halo Model
Mqv
Very Weak
Garp
Neutral
Mqv Small
Neutral
Momentum
Price
Very Weak
Earnings
Very Weak
Growth
Earnings
Neutral
Dividends
Strong
Quality
Capital Efficiency
Strong
Balance Sheet
Very Weak
Valuation
News & Announcements
No announcements available.
Key Stakeholders
| Name | Title |
| Saltzman Family | Individual |
| Royal Bafokeng Holdings (Pty) Ltd. | Subsidiary |
| Stansh Pty Ltd. | Private Company |